Novonesis
415.6
DKK
+0.65 %
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
20 following
+0.65%
-3.82%
-10.04%
-0.95%
+11.99%
+16.71%
-15.85%
+27.45%
+1,023.24%
investors.novozymes.com/investors/default.aspx
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Revenue
17.9B
EBIT %
22.21 %
P/E
38.06
Dividend yield-%
1.49 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
NSIS B
Daily low / high price
407.6 / 416.9
DKK
Market cap
194.62B DKK
Turnover
159.01M DKK
Volume
385K
Financial calendar
Annual report
2025-02-26
General meeting
2025-04-03
Interim report
2025-08-13
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Novo Holdings A/S | 25.5 % | 72.4 % |
ShowingAll content types
Major shareholder announcement
Major shareholder announcement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools